Company: CSLMF
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076682
Chunk: 50

Company: CSLM ACQUISITION CORP.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 50
---
) the underwriter will waive the deferred underwriter fee payable and
any deferred underwriting commissions payable pursuant to the underwriter agreement dated April 22, 2021. For avoidance of doubt, the
agreement applies only if the initial Business Combination is consummated, and the transfer of shares is effective and completed. Except
as specifically amended in the agreement, all terms of the underwriting agreement dated April 22, 2021 shall remain in full force and
effect.

Commitments and Contingencies

Registration and Shareholder Rights

The holders of the Founder Shares, Private Placement Warrants, and
warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the
Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the Founder
Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective
date of the Initial Public Offering, requiring the Company to register such securities for resale. The holders will have the right to
require us to register for resale these securities pursuant to a shelf registration under Rule 415 under the Securities Act. The holders
of a majority of these securities will also be entitled to make up to three demands, plus short form registration demands, that we register
such securities. In addition, the holders will be entitled to certain “piggy-back” registration rights with respect to registration
statements filed subsequent to our completion of our initial business combination. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.

24

Underwriting Agreement

The Company granted the underwriter a 45-day option from the date
of the Initial Public Offering to purchase up to 2,475,000 additional Units to cover over-allotments, if any, at the Initial Public
Offering price less the underwriting discount. The underwriters exercised the over-allotment option in full on January 18, 2022, the
date of the Initial Public Offering. The underwriter was entitled to a cash underwriting discount of $0.20 per Unit, or $3,795,000
in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, the underwriter is entitled to a
deferred fee of $0.35 per Unit, or $6,641,250 in the aggregate. The deferred fee is payable to the underwriter from